ReviewCancer medicine2023

Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer.

Zein Alabdin Hannouneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.